NO20051212L - Ny kombinasjon av glukokortikoider og PDE-4 inhibitorer for behandling av luftveissykdommer, allergiske sykdommer, astma og COPD - Google Patents

Ny kombinasjon av glukokortikoider og PDE-4 inhibitorer for behandling av luftveissykdommer, allergiske sykdommer, astma og COPD

Info

Publication number
NO20051212L
NO20051212L NO20051212A NO20051212A NO20051212L NO 20051212 L NO20051212 L NO 20051212L NO 20051212 A NO20051212 A NO 20051212A NO 20051212 A NO20051212 A NO 20051212A NO 20051212 L NO20051212 L NO 20051212L
Authority
NO
Norway
Prior art keywords
diseases
pde
copd
asthma
treatment
Prior art date
Application number
NO20051212A
Other languages
English (en)
Other versions
NO20051212D0 (no
Inventor
Robert Hermann
Mathias Locher
Original Assignee
Viatris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viatris Gmbh filed Critical Viatris Gmbh
Publication of NO20051212D0 publication Critical patent/NO20051212D0/no
Publication of NO20051212L publication Critical patent/NO20051212L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Oppfinnelsen vedrører en ny kombinasjon av et glukokortikoid, spesielt loteprednol, og i det minste en fosfodiesterase-4 inhibitor (PDE-4 inhibitor), spesielt hydroksyindolderivatet N-(3,5-diklorpyridin-4-yl)- 2-[l-(4-fluorbenzyl)-5-hydroksyindyl-3-yll-2oksoacetamid, for samtidig, sekvensiell eller separat administrering ved behandling av luftveissykdommer, allergiske sykdommer, astma og kronisk obstruktive limgesykdommer (C0PI3).
NO20051212A 2002-08-09 2005-03-08 Ny kombinasjon av glukokortikoider og PDE-4 inhibitorer for behandling av luftveissykdommer, allergiske sykdommer, astma og COPD NO20051212L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10236688 2002-08-09
PCT/EP2003/008607 WO2004019984A1 (de) 2002-08-09 2003-08-04 Neue kombination von glucocorticoiden und pde-4-inhibitoren zur behandlung von atemwegserkrankungen, allergischen erkrankungen, asthma und copd

Publications (2)

Publication Number Publication Date
NO20051212D0 NO20051212D0 (no) 2005-03-08
NO20051212L true NO20051212L (no) 2005-03-08

Family

ID=31968961

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051212A NO20051212L (no) 2002-08-09 2005-03-08 Ny kombinasjon av glukokortikoider og PDE-4 inhibitorer for behandling av luftveissykdommer, allergiske sykdommer, astma og COPD

Country Status (19)

Country Link
US (1) US20050288265A1 (no)
EP (1) EP1526870B1 (no)
JP (1) JP2005539042A (no)
CN (1) CN1308038C (no)
AT (1) ATE361076T1 (no)
AU (1) AU2003255365B2 (no)
CA (1) CA2492645A1 (no)
CY (1) CY1107696T1 (no)
DE (1) DE50307184D1 (no)
DK (1) DK1526870T3 (no)
EA (1) EA008981B1 (no)
ES (1) ES2285238T3 (no)
HK (1) HK1078463A1 (no)
HR (1) HRP20050224B1 (no)
MX (1) MXPA05001573A (no)
NO (1) NO20051212L (no)
PT (1) PT1526870E (no)
UA (1) UA82323C2 (no)
WO (1) WO2004019984A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10241407A1 (de) * 2002-09-06 2004-03-18 Elbion Ag Behandlung nicht allergischer Rhinitis durch selektive Phosphodiesterase 4-Hemmstoffe
PL1713473T3 (pl) 2004-02-06 2013-08-30 Meda Pharma Gmbh & Co Kg Kombinacja leków antycholinergicznych i glikokortykoidów do długotrwałego leczenia astmy i POChP
CN101518532A (zh) 2004-02-06 2009-09-02 Meda制药有限及两合公司 用于呼吸道疾病治疗的抗胆碱能药和4型磷酸二酯酶抑制剂的组合
MX2007011273A (es) 2005-03-16 2007-11-08 Meda Pharma Gmbh & Co Kg La combinacion de anticolinergicos y antagonistas del receptor de leucotrieno para el tratamiento de enfermedades respiratorias.
US8506934B2 (en) 2005-04-29 2013-08-13 Robert I. Henkin Methods for detection of biological substances
WO2007071313A2 (en) 2005-12-21 2007-06-28 Meda Pharma Gmbh & Co Kg Combination of anticholinergics, glucocorticoids, beta2-ag0nists, pde4 inhibitor and antileukotriene for the treatment of inflammatory diseases
WO2007103373A2 (en) * 2006-03-07 2007-09-13 Combinatorx, Incorporated Compositions and methods for the treatment of immunoinflammatory disorders
US8293489B2 (en) 2007-01-31 2012-10-23 Henkin Robert I Methods for detection of biological substances
US8580801B2 (en) 2008-07-23 2013-11-12 Robert I. Henkin Phosphodiesterase inhibitor treatment
CN102309756A (zh) * 2010-07-02 2012-01-11 天津金耀集团有限公司 含有磷酸二酯酶4抑制剂和糖皮质激素的治疗皮肤病的复方药物
US11596599B2 (en) 2012-05-03 2023-03-07 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
US9827191B2 (en) 2012-05-03 2017-11-28 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
EP2844295A1 (en) 2012-05-03 2015-03-11 Kala Pharmaceuticals, Inc. Pharmaceutical nanoparticles showing improved mucosal transport
WO2013166408A1 (en) * 2012-05-03 2013-11-07 Kala Pharmaceuticals, Inc. Pharmaceutical nanoparticles showing improved mucosal transport
US10864219B2 (en) 2012-05-03 2020-12-15 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
US20160030435A1 (en) * 2013-03-15 2016-02-04 Robert I HENKIN Phosphodiesterase inhibitor treatment
US10598672B2 (en) 2014-02-18 2020-03-24 Cyrano Therapeutics, Inc. Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE449106B (sv) * 1980-07-10 1987-04-06 Otsuka Pharma Co Ltd Steroid med anti-inflammatorisk verkan samt komposition innehallande denna
US4996335A (en) * 1980-07-10 1991-02-26 Nicholas S. Bodor Soft steroids having anti-inflammatory activity
DK1014943T3 (da) * 1997-02-05 2002-10-14 Jago Res Ag Medicinske aerosolformuleringer
TR200003130T2 (tr) * 1998-04-28 2001-01-22 Arzneimittelwerk Dresden Gmbh Yeni hidroksiindoller, bunların fosfodiesteraz 4 inhibitörleri olarak kullanımları ve hazırlanmaları için işlemler
DE19917504A1 (de) * 1999-04-17 2000-10-19 Dresden Arzneimittel Verwendung von Hydroxyindolen, die Inhibitoren der Phosphodiesterase 4 sind, zur Therapie chronisch obstruktiver Lungenerkrankungen
DE19947234A1 (de) * 1999-09-30 2001-04-05 Asta Medica Ag Neue Kombination von Loteprednol und Antihistaminika
US20040214805A1 (en) * 1999-11-02 2004-10-28 Smithkline Beecham Corporation Method and compositions for treating pulmonary diseases
AR029189A1 (es) * 1999-11-02 2003-06-18 Smithkline Beecham Corp Uso de un inhibidor de fosfodiesterasa 4 y un corticoesteroide antiinflamatorio en forma combinada, separadamente o separadamente secuencial para la preparacion de un medicamento
CN1173697C (zh) * 2000-05-19 2004-11-03 爱尔康公司 用于治疗过敏性疾病的苯胺二硫化物衍生物
GB0123951D0 (en) * 2001-10-05 2001-11-28 Glaxo Group Ltd Therapies for treating respiratory diseases
EP1441730B1 (en) * 2001-11-05 2006-08-09 Merck Patent GmbH Hydrazono-malonitriles
US20030092706A1 (en) * 2001-11-09 2003-05-15 Johannes Barsig Combination

Also Published As

Publication number Publication date
ES2285238T3 (es) 2007-11-16
WO2004019984A1 (de) 2004-03-11
AU2003255365B2 (en) 2009-02-19
HRP20050224B1 (en) 2007-12-31
DK1526870T3 (da) 2007-09-10
AU2003255365A1 (en) 2004-03-19
NO20051212D0 (no) 2005-03-08
US20050288265A1 (en) 2005-12-29
UA82323C2 (uk) 2008-04-10
HK1078463A1 (en) 2006-03-17
CN1674939A (zh) 2005-09-28
DE50307184D1 (de) 2007-06-14
CY1107696T1 (el) 2013-04-18
CN1308038C (zh) 2007-04-04
EA008981B1 (ru) 2007-10-26
ATE361076T1 (de) 2007-05-15
CA2492645A1 (en) 2004-03-11
HRP20050224A2 (en) 2005-04-30
PT1526870E (pt) 2007-07-09
JP2005539042A (ja) 2005-12-22
EP1526870B1 (de) 2007-05-02
EA200500328A1 (ru) 2005-06-30
EP1526870A1 (de) 2005-05-04
MXPA05001573A (es) 2005-04-25

Similar Documents

Publication Publication Date Title
NO20051212L (no) Ny kombinasjon av glukokortikoider og PDE-4 inhibitorer for behandling av luftveissykdommer, allergiske sykdommer, astma og COPD
MXPA02011311A (es) Composicion novedosa.
SE0200356D0 (sv) Novel use
MXPA03011515A (es) Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos, corticoesteroides y agentes betamimeticos.
NO20045434L (no) En kombinasjon av en NMDA-antagonist og acetylkolinesteraseinhibitorer for behandlingen av Alzheimers sykdom
BG105762A (en) Peptidyl heterocyclic ketones useful as tryptase inhibitors
IS7898A (is) Ný samverkandi samsetning sem felur í sér róflúmílast og formóteról
WO2005041864A3 (en) Combination of cyclooxygenase-2 inhibitor and phosphodiesterase 4 inhibitor and method
IS7899A (is) Samverkandi samsetning sem felur í sér róflúmílast og (R.R)-formóteról
SE9900834D0 (sv) Novel combination
NO20044321L (no) Piperazinyl- eller piperidinylamin-sulfaminsyreamider som inhibitorer av steroid sulfatase
MXPA04007294A (es) Composicion para inhalacion.
NO20005147D0 (no) FremgangsmÕter og sammensetninger som benytter terfenadinmetabolitter i kombinasjon med leukotrienhemmere
NO20045343L (no) Ny kombinasjon for behandling av luftveisforstyrrelser
NO20045344L (no) Kombinasjon for behandling av luftveisforstyrrelser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application